In a series of interviews, experts highlight lasting health care innovations that emerged during the COVID-19 pandemic, including telemedicine, artificial intelligence (AI), and home-based treatment.
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.
Three of Lubbock's civic leaders were on a collision course for a pandemic that would alter life in Lubbock for years to come ...
COVID-19 infections in Delta County are at their lowest point in more than a year-and-a-half, according to data from the Michigan Department of Health and Human Services. According to MDHHS — which ...
Dr. Stephen May said one of the most crucial lessons was understanding that the disease itself evolved which required a ...
Health departments across Indiana will be impacted by the sudden stoppage of COVID-19 relief funds by the Trump ...
UK officials published a watch list of 24 “priority pathogen” families on Tuesday, hoping to boost readiness in case another ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback